Coronary collateral size, flow capacity, and growth estimates from the angiogram in patients with obstructive coronary disease

Circulation

Volumn 105, Issue 2, 2002, Pages 168-173

  Rockstroh, Julia ^a   Brown, B Greg ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Angiography; Collateral circulation; Gene therapy; Growth substances; Lipids

Indexed keywords

COLESTIPOL; LIPOPROTEIN; MEVINOLIN; NICOTINIC ACID;

ANGINA PECTORIS; ARTICLE; CINEANGIOCARDIOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MATHEMATICAL MODEL; PHANTOM; PREDICTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ANGINA PECTORIS; ANTILIPEMIC AGENTS; COLLATERAL CIRCULATION; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY DISEASE; FOLLOW-UP STUDIES; HUMANS; LIPID METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; REGIONAL BLOOD FLOW; REPRODUCIBILITY OF RESULTS;

EID: 0037080489     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc0202.102120     Document Type: Article

References (31)

1. Functional importance of the human coronary collateral circulation
2. Coronary collateral vessels: Spectrum of physiologic capabilities with respect to providing rest and stress myocardial perfusion, maintenance of left ventricular function and protection against infarction
3. Functional significance of collateral blood flow in patients with recent acute myocardial infarction: A study using myocardial contrast echocardiography
4. The magnitude and time of development of the collateral circulation in occluded femoral, carotid and coronary arteries
5. Coronary collateral flow following acute coronary occlusion: A diastolic phenomenon
6. Effect of nitroglycerin and dipyridamole on regional coronary resistance
7. Coronary collateral development in swine after coronary artery occlusion
8. Influence of coronary collateral vessels on myocardial infarct size in humans: Results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial. The TIMI Investigators
9. Return of left ventricular function after reperfusion in patients with myocardial infarction: Importance of subtotal stenoses or intact collaterals
10. Angiographic methods to assess human coronary angiogenesis
11. Quantitative coronary arteriograpby: Estimation of dimensions, hemodynamic resistance, and atheroma mass of coronary artery lesions using the arteriogram and digital computation
12. Intrathoracic spatial location of specified coronary segments on the normal human heart: Applications in quantitative arteriography, assessment of regional risk and contraction, and anatomic display
13. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B
14. Measurement of coronary sinus blood flow by continuous thermodilution in man
15. -/- mice
16. Grading of angina pectoris
17. Molecular mechanisms of coronary collateral vessel growth
18. Mechanisms of angiogenesis and arteriogenesis
19. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease
20. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion
21. Cellular and molecular mechanisms of endothelial cell dysfunction
22. Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion
23. Angiogenesis in ischemic heart disease
24. Multifactorial basis for coronary collateralization: A complex adaptive response to ischemia
25. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury
26. Angiogenesis and vasculogenesis in treatment of cardiovascular disease
27. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis
28. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia